scholarly article | Q13442814 |
P356 | DOI | 10.1093/OXFORDJOURNALS.ANNONC.A059157 |
P698 | PubMed publication ID | 7542021 |
P50 | author | Bengt Glimelius | Q30830855 |
P2093 | author name string | L Påhlman | |
O Nyrén | |||
P O Sjödén | |||
W Graf | |||
K Hoffman | |||
U Haglund | |||
P433 | issue | 3 | |
P921 | main subject | cost-effectiveness analysis | Q1754768 |
chemotherapy | Q974135 | ||
P304 | page(s) | 267-274 | |
P577 | publication date | 1995-03-01 | |
P1433 | published in | Annals of Oncology | Q326122 |
P1476 | title | Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. | |
P478 | volume | 6 |
Q61868238 | A clinical nomogram for predicting long-term survival in advanced colorectal cancer |
Q44480327 | A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer |
Q36614969 | A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer |
Q35768031 | Advanced gastric cancer in jordan from 2004 to 2008: a study of epidemiology and outcomes |
Q36291291 | Assessing patients' needs and preferences in the management of advanced colorectal cancer |
Q33761838 | Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature |
Q36106736 | Benefit-risk assessment of irinotecan in advanced colorectal cancer |
Q24236634 | Chemotherapy for advanced gastric cancer |
Q24244040 | Chemotherapy for advanced gastric cancer |
Q38604012 | Chemotherapy for advanced gastric cancer. |
Q33541099 | Chemotherapy for advanced pancreatic cancer: it may no longer be ignored |
Q77203325 | Chemotherapy in advanced pancreatic adenocarcinoma |
Q35108798 | Chemotherapy in gastric cancer: a review and updated meta-analysis |
Q61868286 | Chemotherapy of oesophago-gastric cancer |
Q35039124 | Colorectal cancer in the elderly: is palliative chemotherapy of value? |
Q93911723 | Colorectal cancer: treatment of advanced disease |
Q35094252 | Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis |
Q58883872 | Cost identification of Nordic FLIRI, Nordic FLOX, XELIRI and XELOX in first-line treatment of advanced colorectal cancer in Sweden – A clinical practice model approach |
Q39015252 | Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer |
Q34615968 | Cost-effectiveness analysis of colorectal cancer treatments. |
Q35382059 | Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer |
Q83204605 | Cost-effectiveness of gemcitabine + cisplatin vs. gemcitabine monotherapy in advanced biliary tract cancer |
Q77221752 | Cost-effectiveness of hepatic artery infusion chemotherapy |
Q46320846 | Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer |
Q34759802 | Cost-effectiveness of preoperative biliary drainage for obstructive jaundice in pancreatic and periampullary cancer |
Q37246292 | Costs and trends in pancreatic cancer treatment |
Q34427755 | Disease management considerations: disease management considerations |
Q73304002 | Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer |
Q50666978 | Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer. |
Q52223063 | Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer. |
Q35629061 | First-line treatment strategies to improve survival in patients with advanced colorectal cancer |
Q36329208 | Integrating palliative medicine into an oncology practice |
Q36254159 | Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144. |
Q35666090 | Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy |
Q61868280 | Medical management of advanced gastric cancer |
Q33413448 | Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study |
Q40860038 | Multidisciplinary case teams: an approach to the future management of advanced colorectal cancer |
Q33875868 | New directions in the treatment of colorectal cancer: a look to the future |
Q35111182 | Palliative Treatment of Patients with Colorectal Cancer |
Q41739152 | Palliative chemotherapy |
Q34021183 | Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group |
Q57693104 | Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration |
Q33658659 | Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial |
Q53604465 | Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. |
Q57758626 | Should patients with advanced colorectal cancer be treated with chemothreapy? |
Q24246675 | Supportive care for patients with gastrointestinal cancer |
Q36620872 | Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials |
Q50996446 | The value of palliative gastrectomy in gastric cancer with distant metastasis. |
Q33545323 | Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer |
Q36292847 | Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer |
Q78316496 | [Measure of quality of life in patients with metastatic colorectal cancer: techniques and main results] |
Q73869646 | [Role of first-line palliative chemotherapy in metastatic colorectal cancer] |
Q79861920 | [Surgical treatment of osseous metastases of the pelvis] |
Q86578814 | [Treatment of gastric cancer] |
Search more.